Related Experiment Video
Updated: Mar 15, 2026

Rapid Point-of-Care Assay of Enoxaparin Anticoagulant Efficacy in Whole Blood
Published on: October 12, 2012
Direct Oral Anticoagulants: Monitoring Anticoagulant Effect
1Clinical and Translational Research, Hemostasis, Platelet Immunology, and Genomics Laboratory, Bloodworks Northwest, University of Washington School of Medicine, 921 Terry Avenue, Seattle, WA 98104, USA.
Abstract:
In some clinical settings laboratory measurement of direct oral anticoagulants effect is helpful in guiding medical care, such as life-threatening bleeding, need for emergency surgery, renal impairment, severe hepatic failure, extremes of body weight, or in patients with bleeding or thrombosis on therapy. This article reviews approaches to laboratory testing to assess the anticoagulant effect of these drugs. Because of the wide variation in levels measured in patients on therapy and minimal clinical data from dose adjustment, dose adjustment based on levels is not currently advised. In addition, these drugs interfere with many clot-based laboratory tests and caution is advised in interpreting these tests in patients on direct oral anticoagulants.
More Related Videos
Related Concept Videos
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Therapeutic Drug Monitoring: Affecting Factors
Venous Thrombosis III: Interprofessional Care
Therapeutic Drug Monitoring: Drug Analysis Methods
Venous Thrombosis IV: Nursing Management

